Ionis Pharmaceuticals Inc (FRA:ISI)
€ 33.48 -0.13 (-0.39%) Market Cap: 5.40 Bil Enterprise Value: 4.42 Bil PE Ratio: 0 PB Ratio: 8.55 GF Score: 60/100

Ionis Pharmaceuticals Inc at BMO Capital Markets Prescription for Success Healthcare Conference Transcript

Jun 25, 2019 / 01:20PM GMT
Release Date Price: €56.26 (-0.48%)
Guyn Kim
BMO Capital Markets Equity Research - Analyst

All right. Good morning. My name is Do Kim. I'm one of the biotech analysts at BMO. Happy to have with us Brett Monia, COO of Ionis.

Questions & Answers

Guyn Kim
BMO Capital Markets Equity Research - Analyst

Brett, just to start off, as we recognize the 30 years that Ionis has been around, could you reflect on what the company has achieved in that time, where you are today and what we could expect as you transition to CEO?

Brett P. Monia
Ionis Pharmaceuticals, Inc. - Founder, COO, Senior VP of Translational Medicine & Director

Sure thing, Do, and happy to -- and good morning, everybody. I'm glad to be here. Thanks for the invitation to talk a little bit about Ionis and where we're at today.

So yes, indeed, this is our 30th-year anniversary, and there's a lot of celebrating going on right now in San Diego because we're very proud of what we've accomplished over the last 30 years. I think at the high level, Do, what we've done was

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot